Pontomesencephalic Atrophy and Postural Instability in Wilson Disease

References

1. 1.↵
   2. Bull PC,
   3. Thomas GR,
   4. Rommens JM, et al

   . The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327–37 doi:10.1038/ng1293-327 pmid:8298639

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Daroff RB,
   2. Fenichel GM,
   3. Jankovic J, et al.

   2. Jankovic J

   . Movement disorder. In: Daroff RB, Fenichel GM, Jankovic J, et al., eds. Bradley's Neurology in Clinical Practice. 6th ed. Philadelphia: Elseiver/Saunders; 2012:1762–1801
3. 3.↵
   2. Kalita J,
   3. Kumar V,
   4. Ranjan A, et al

   . Role of oxidative stress in the worsening of neurologic Wilson disease following chelating therapy. Neuromolecular Med 2015;17:364–72 doi:10.1007/s12017-015-8364-8 pmid:26224517

   CrossRefPubMed
4. 4.↵
   2. Sinha S,
   3. Taly AB,
   4. Ravishankar S, et al

   . Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology 2006;48:613–21 doi:10.1007/s00234-006-0101-4 pmid:16752136

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Broussolle E,
   3. Trocello JM,
   4. Woimant F, et al

   . Samuel Alexander Kinnier Wilson: Wilson's disease, Queen Square and neurology. Rev Neurol (Paris) 2013;169:927–35 doi:10.1016/j.neurol.2013.04.006 pmid:24125461

   CrossRefPubMed
6. 6.↵
   2. Singh S,
   3. Behari M

   . Wilson's disease. J Assoc Physicians India 2003;51:183–90 pmid:12725264

   PubMed
7. 7.↵
   2. Prashanth LK,
   3. Sinha S,
   4. Taly AB, et al

   . Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord 2010;25:672–78 doi:10.1002/mds.22689 pmid:20437536

   CrossRefPubMed
8. 8.↵
   2. Ranjan A,
   3. Kalita J,
   4. Kumar S, et al

   . A study of MRI changes in Wilson disease and its correlation with clinical features and outcome. Clin Neurol Neurosurg 2015;138:31–36 doi:10.1016/j.clineuro.2015.07.013 pmid:26278999

   CrossRefPubMed
9. 9.↵
   2. Kim YH,
   3. Ma HI,
   4. Kim YJ

   . Utility of the midbrain tegmentum diameter in the differential diagnosis of progressive supranuclear palsy from idiopathic Parkinson's disease. J Clin Neurol 2015;11:268–74 doi:10.3988/jcn.2015.11.3.268 pmid:26174787

   CrossRefPubMed
10. 10.↵
    2. Quattrone A,
    3. Nicoletti G,
    4. Messina D, et al

    . MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008;246:214–21 doi:10.1148/radiol.2453061703 pmid:17991785

    CrossRefPubMed
11. 11.↵
    2. Morelli M,
    3. Arabia G,
    4. Novellino F, et al

    . MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study. Neurology 2011;77:1042–47 doi:10.1212/WNL.0b013e31822e55d0 pmid:21832222

    Abstract/FREE Full Text
12. 12.↵
    2. Zweig RM,
    3. Jankel WR,
    4. Hedreen JC, et al

    . The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 1989;26:41–46 doi:10.1002/ana.410260106 pmid:2549845

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Pahapill PA,
    3. Lozano AM

    . The pedunculopontine nucleus and Parkinson's disease. Brain 2000;123(pt 9):1767–83 doi:10.1093/brain/123.9.1767 pmid:10960043

    Abstract/FREE Full Text
14. 14.↵
    2. Kuo SH,
    3. Kenney C,
    4. Jankovic J

    . Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov Disord 2008;23:616–19 doi:10.1002/mds.21917 pmid:18181207

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Masdeu JC,
    3. Alampur U,
    4. Cavaliere R, et al

    . Astasia and gait failure with damage of the pontomesencephalic locomotor region. Ann Neurol 1994;35:619–21 doi:10.1002/ana.410350517 pmid:8179307

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Hathout GM,
    3. Bhidayasiri R

    . Midbrain ataxia: an introduction to the mesencephalic locomotor region and the pedunculopontine nucleus. AJR Am J Roentgenol 2005;184:953–56 doi:10.2214/ajr.184.3.01840953 pmid:15728623

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Kalita J,
    3. Kumar V,
    4. Misra UK, et al

    . A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings. J Neuroimmunol 2014;274:141–48 doi:10.1016/j.jneuroim.2014.06.013 pmid:25002079

    CrossRefPubMed
18. 18.↵
    2. Roberts EA,
    3. Schilsky ML

    ; American Association for Study of Liver Disease (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089–111 doi:10.1002/hep.22261 pmid:18506894

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Grimm G,
    3. Prayer L,
    4. Oder W, et al

    . Comparison of functional and structural brain disturbances in Wilson's disease. Neurology 1991;41:272–76 doi:10.1212/WNL.41.2_Part_1.272 pmid:1992374

    Abstract/FREE Full Text
20. 20.↵
    2. Krystkowiak P,
    3. du Montcel ST,
    4. Vercueil L, et al

    ; SPIDY Group. Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia. Mov Disord 2007;22:685–89 doi:10.1002/mds.21392 pmid:17274034

    CrossRefPubMed
21. 21.↵
    1. Fahn S,
    2. Marsden CD,
    3. Calne DB, et al.

    2. Fahn S,
    3. Elton RL

    , members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, et al., eds. Recent Developments in Parkinson's Disease. Vol. 2. New York: Raven Press; 1986:153–63, 293–304
22. 22.↵
    2. Das SK,
    3. Ray K

    . Wilson's disease: an update. Nat Clin Pract Neurol 2006;2:482–93 doi:10.1038/ncpneuro0291 pmid:16932613

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Kalita J,
    3. Kumar V,
    4. Misra UK

    . A study on apoptosis and anti-apoptotic status in Wilson disease. Mol Neurobiol 2016;53:6659–67 doi:10.1007/s12035-015-9570-y pmid:26646538

    CrossRefPubMed
24. 24.↵
    2. Bartels AL,
    3. Leenders KL

    . Brain imaging in patients with freezing of gait. Mov Disord 2008;23(suppl 2):S461–67 doi:10.1002/mds.21912 pmid:18668627

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Kalita J,
    3. Ranjan A,
    4. Misra UK

    . Oromandibular dystonia in Wilson disease. Movement Disorders Clinical Practice 2015;2:253–59 doi:10.1002/mdc3.12171

    CrossRef